483
Eisai Company Ltd.Eisai Company Ltd. – FDA 483, Jun 28, 2019
Record Details
An FDA inspection of Eisai Company Ltd., a bulk finished drug manufacturer in Kakamigahara, Japan, revealed deficiencies in production and process controls and equipment maintenance. The firm failed to document developmental studies for tablet dissolution parameters and lacked proper records for cleaning and maintenance activities, including observed material accumulation and undocumented air vent devices.
View Company Profile
ID · 74314d7e-eb90-4dca-9b43-ce25b021db49
Other documents for Eisai Company Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.